Chromatographic peak retention times and MS fragmentation designs from all tested pyrazolam pill batches matched those on the reference standard. All details had been when compared to the released chromatographic monographs [forty one,56,57], to substantiate the presence of pyrazolam in all pill batches. Quantitative Evaluation confirmed major inte